RT dose reduction in HPV positive oropharyngeal cancer

Since we had such a great discussion about prostate hypofractionation, I thought we could go over another controversial topic. David Raben gave an excellent presentation to our residents last year on dose reduction (perhaps to 60 Gy or so with a single cycle of CDDP) for p16 positive oropharyngeal SCC. Logically it makes good sense due to Ang's retrospective finding of better prognosis in these patients. I'm wondering if any of your institutions are enrolling patients on Phase I/II... RT dose reduction in HPV positive oropharyngeal cancer
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Source Type: forums